RA Capital Management buys USD 456,297 of Artiva Biotherapeutics common sharesPUBT·1 day ago, 04:13 PMARTV-3.16%
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives Average Recommendation of "Moderate Buy" from AnalystsMarket Beat·2 days ago, 09:14 AMARTV-3.16%
Inside the M&A Shuffles: Takeda, ZTO, and Pentair's $1.4B Buyout SignalGlobal Report·Jul 29 at 04:19 AMTAK-0.93%ZTO+0.67%
Major Investor Doubles Down on Artiva Biotherapeutics With Bold New MoveTip Ranks·Jul 28 at 09:04 PMARTV-3.16%
RA Capital Management reports USD 412,776 Artiva Biotherapeutics common share purchasePUBT·Jul 28 at 04:24 PMARTV-3.16%
RA Capital Management acquires USD 2.62 million of Artiva Biotherapeutics common sharesPUBT·Jul 23 at 08:23 PMARTV-3.16%
Major Insider Move Signals Growing Confidence in Artiva BiotherapeuticsTip Ranks·Jul 20 at 09:02 PMARTV-3.16%
RA Capital Management reports $1.43 million purchase of Artiva Biotherapeutics sharesPUBT·Jul 20 at 05:09 PMARTV-3.16%
Artiva Biotherapeutics issues 288,800 RSUs to 17 new hires under inducement planPUBT·Jul 17 at 06:30 AMARTV-3.16%
Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ARTV Stock NewsStockTitan·Jul 16 at 10:30 PMARTV-3.16%
RA Capital Management reports purchase of Artiva Biotherapeutics common shares worth $194,237.66PUBT·Jul 14 at 06:01 PMARTV-3.16%
